Product code LCO— Hematology
ASSERACHROM HPIA TEST KIT
- Classification name
- Platelet Factor 4 Radioimmunoassay
- Device class
- Class 2
- Regulation
- 21 CFR 864.7695
- Advisory panel
- Hematology
- Total cleared
- 13
- First cleared
- Most recent
Market context for product code LCO
FDA has cleared devices under product code LCO between 1986 and 2025, filed by 9 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2025
- 2020
- 2017
- 2016
- 2007
- 2006
- 2004
- 2001
- 1999
- 1989
- 1986
Top applicants under product code LCO
Recent clearances under product code LCO
- K243374 — HemosIL CL HIT-IgG(PF4-H)
- K201570 — PF4 Enhanced assay
- K201311 — PF4 IgG assay
- K170854 — HemosIL AcuStar HIT-IgG(PF4-H), HemosIL AcuStar HIT Controls
- K153137 — HemosIL HIT-Ab(PF4-H), HemosIL HIT-Ab(PF4-H) Controls
- K071781 — PF4 IGG
- K071255 — ZYMUTEST HIA IGGAM, ZYMUTEST IGG, MODEL RK040D, RK040A
- K053559 — PF4 ENHANCED SOLID PHASE ELISA
- K040293 — HEALTHTEST HEPARIN/PLATELET FACTOR 4 ANTIBODY ASSAY
- K003767 — ASSERACHROM HPIA TEST KIT
- K983379 — GTI-PF4 ELISA
- K890633 — ENZYGNOST PLATELET FACTOR 4 (PF4) KIT
- K862774 — ASSERACHROM PF4 KIT
Data sourced from openFDA. This site is unofficial and independent of the FDA.